Display Settings:

Format

Send to:

Choose Destination
Asian Pac J Cancer Prev. 2012;13(8):4093-5.

Pituitary adenoma biomarkers identified using proteomic fingerprint technology.

Author information

  • 1Department of Neurosurgery, Taizhou Municipal Hospital, Taizhou Medical College, Taizhou, China. kaiyuzhoucn@163.com

Abstract

OBJECTIVE:

To determine whether pituitary adenomas can be diagnosed by identifying protein biomarkers in the serum.

METHODS:

We compared serum proteins from 65 pituitary adenoma patients and 90 healthy donors using proteomic fingerprint technology combining magnetic beads with matrix assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-MS).

RESULTS:

A total of 42 M/Z peaks were identified as related to pituitary adenoma (P<0.01). A diagnostic model established based on three biomarkers (3382.0, 4601.9, 9191.2) showed that the sensitivity of diagnosing pituitary adenoma was 90.0% and the specificity was 88.3%. The model was further tested by blind analysis showing that the sensitivity was 88.0% and the specificity was 83.3%.

CONCLUSIONS:

These results suggest that proteomic fingerprint technology can be used to identify pituitary adenoma biomarkers and the model based on three biomarkers (3382.0, 4601.9, 9191.2) provides a powerful and reliable method for diagnosing pituitary adenoma.

PMID:
23098522
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Asian Pacific Organization for Cancer Prevention
    Loading ...
    Write to the Help Desk